重要信号:孕妇和婴儿中流感和百日咳的负担与预防——美国
分析监测数据发现,2010-11至2017-18季节孕妇占15-44岁女性流感相关住院的24%-34%,2010-2017年<2月龄婴儿百日咳相关住院共3928例。2019年4月调查显示孕妇流感疫苗接种率53.7%、百白破疫苗54.9%;提供接种或转诊的孕妇中接种率分别为65.7%和70.5%。常见未接种原因包括认为疫苗无效(流感17.6%)、不知每次妊娠均需接种(百白破37.9%)及对婴儿安全担忧(流感15.9%;百白破17.1%)。
要点
- 孕妇占15-44岁女性流感相关住院的24%-34%(2010-11至2017-18季节)。
- 2010-2017年<2月龄婴儿百日咳相关住院共3928例(年范围262-743例)。
- 提供接种或转诊的孕妇中流感疫苗和百白破疫苗接种率分别为65.7%和70.5%。
核心结论
- 许多孕妇即使被提供疫苗接种也未接种推荐疫苗,无法保护自身和婴儿。
- CDC和提供方组织有资源帮助提供方传达有力、具体且回应孕妇担忧的流感和百白破疫苗接种建议。
研究设计与样本
- 分析监测数据以确定孕妇流感相关住院及婴儿流感/百日咳相关住院和死亡。
- 2019年3月27日至4月8日对18-49岁自2018年8月1日以来曾怀孕女性进行互联网小组调查。
- 在2018年10月至2019年1月期间怀孕且流感疫苗接种状态已知的应答者(2097人)中评估孕前或孕期流感疫苗接种。
- 在调查日之前活产且百白破状态已知的应答者(817人)中评估孕期百白破接种。
主要发现
- 2010-11至2017-18季节,孕妇占15-44岁女性流感相关住院的24%-34%。
- 2010至2017年,<2月龄婴儿报告百日咳相关住院共3928例(年范围262-743例)。
- 截至2019年4月,孕妇流感疫苗和百白破疫苗覆盖率分别为53.7%和54.9%。
- 提供接种或转诊的孕妇中,65.7%接种流感疫苗,70.5%接种百白破疫苗。
- 未接种常见原因:认为疫苗无效(流感17.6%)、不知每次妊娠均需接种(百白破37.9%)、对婴儿安全担忧(流感15.9%;百白破17.1%)。
临床怎么用
- CDC和提供方组织有资源帮助提供方传达有力、具体且回应孕妇担忧的流感和百白破疫苗接种建议。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vaccinating pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can reduce influenza and pertussis risk for themselves and their infants. METHODS: Surveillance data were analyzed to ascertain influenza-associated hospitalization among pregnant women and infant hospitalization and death associated with influenza and pertussis. An Internet panel survey was conducted during March 27-April 8, 2019, among women aged 18-49 years who reported being pregnant any time since August 1, 2018. Influenza vaccination before or during pregnancy was assessed among respondents with known influenza vaccination status who were pregnant any time during October 2018-January 2019 (2,097). Tdap receipt during pregnancy was assessed among respondents with known Tdap status who reported a live birth by their survey date (817). RESULTS: From 2010-11 to 2017-18, pregnant women accounted for 24%-34% of influenza-associated hospitalizations per season among females aged 15-44 years. From 2010 to 2017, a total of 3,928 pertussis-related hospitalizations were reported among infants aged <2 months (annual range = 262-743). Maternal influenza and Tdap vaccination coverage rates reported as of April 2019 were 53.7% and 54.9%, respectively. Among women whose health care providers offered vaccination or provided referrals, 65.7% received influenza vaccine and 70.5% received Tdap. The most commonly reported reasons for nonvaccination were believing the vaccine is not effective (influenza; 17.6%) and not knowing that vaccination is needed during each pregnancy (Tdap; 37.9%), followed by safety concerns for the infant (influenza =15.9%; Tdap = 17.1%). CONCLUSIONS AND IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Many pregnant women do not receive the vaccines recommended to protect themselves and their infants, even when vaccination is offered. CDC and provider organizations' resources are available to help providers convey strong, specific recommendations for influenza and Tdap vaccination that are responsive to pregnant women's concerns.
引用
- Lindley MC, Kahn KE, Bardenheier BH, et al. Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31600186. doi:10.15585/mmwr.mm6840e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。